An experimental therapy being developed by Herantis Pharma for Parkinson’s disease was well tolerated and able to penetrate the blood-brain barrier (BBB), a semipermeable membrane that prevents certain substances, including […] The post Parkinson’s therapy is tolerated well, clearing path for Phase 2 trial appeared first on Parkinson's News Today.
